Liberty Biopharma (CVE:LTY) Stock Price Up ∞ – Still a Buy?

Liberty Biopharma Inc (CVE:LTY)’s share price rose ∞ during mid-day trading on Tuesday. The company traded as high as C$2.00 and last traded at C$2.00. Approximately 700 shares changed hands during mid-day trading, a decline of 97% from the average session volume of 23,286 shares.

Liberty Biopharma Stock Up ∞

The company has a current ratio of 0.12, a quick ratio of 0.12 and a debt-to-equity ratio of 8.19. The company has a market cap of C$21.54 million and a price-to-earnings ratio of -12.66. The firm’s fifty day simple moving average is C$2.00 and its 200 day simple moving average is C$2.00.

About Liberty Biopharma

Liberty Biopharma Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.